May , 2018

Email This Post Email This Post

New AARP Report: Brand Name Drug Prices Increasing Dramatically

Posted by Admin On November - 21 - 2014
AARP warns continuous rise in drug prices has wide-ranging implications

WASHINGTON, DC – Retail prices for brand name prescription drugs widely used by older Americans shot up by an average of nearly 13% in 2013, more than eight times faster than the 1.5% general inflation rate, according to a new AARP Public Policy Institute (PPI) report released today. The report reveals the highest average annual price increase since AARP began tracking prescription drug prices in 2004.

“Higher brand name drug prices can increase health care premiums, deductibles, and other cost-sharing for everyone with health coverage, even for those who don’t take medications,” said AARP Executive Vice President for Policy, Strategy and International Affairs Debra Whitman. “If these price increases continue, we’ll likely see more people-particularly older people, who are often on fixed incomes-stop taking life-saving medications because they simply can’t afford them, leading to higher health care costs down the road.”
Average Brand Name Drug Prices vs General Inflation Rate by Year
Note: Calculations of the average annual brand name drug price change include the
227 drug products most widely used by older Americans (see Appendix A).
“The relentless rise in brand name drug prices also has implications for taxpayer-funded programs like Medicare and Medicaid,” said Whitman. “Higher government spending driven by large price increases eventually affects all Americans in the form of higher taxes, cuts to public programs, or both.”

Almost two-thirds of older Americans take three or more prescription drugs in a given year. For those who take three brand name prescription drugs on a regular basis, their annual cost of therapy would have been more than $8,800 during 2013-more than double the cost seen eight years earlier.

Additionally, increased prices for brand name medications lead to higher out-of-pocket costs for consumers who pay coinsurance, or a percentage of their drug costs, instead of a fixed dollar amount.

According to the AARP PPI report, policymakers should focus on exploring options that reduce the impact of increasing prescription drug prices. AARP continues to work with Congress to help lower prescription drug costs by requiring manufacturer rebates for drugs purchased by Medicare Part D low-income subsidy beneficiaries, improving the approval process for generic versions of biologic drugs, and giving Medicare the authority to negotiate prescription drug prices with drug makers.

Highlights of the Rx Price Watch Report
* The average annual retail price increase for widely used brand name prescription drugs was more than twice as high in 2013 (12.9%) as in 2006 (5.7%).
* In 2013, the average annual cost of one brand name medication used to treat a chronic health condition was nearly $3,000, compared with nearly $1,500 in 2006.
* Retail prices increased for 97% of the 227 brand name prescription drugs in the study’s market basket.
* Seven brand name drugs had average annual retail price increases of over 30% in 2013.

Top 7 drugs with retail price increases over 30% in 2013
% annual increase
Uroxatral 10mg tablet ER 197.5%
Actonel 150mg tablet 78.6%
Solaraze 3% gel 67%
Prandin 2mg tablet 38%
Lunesta 2mg tablet 34%
Aciphex 20mg tablet DR 32.2%
Welchol 625mg tablet 30.6%

“The rise in prescription drug prices negatively impacts consumers, insurers, and employers, as well as taxpayer-funded programs like Medicare and Medicaid,” said Leigh Purvis, Director of Health Services Research, AARP Public Policy Institute, and co-author of the report. “We need to find policy solutions that balance the need for pharmaceutical innovation with the need for improved health and affordability.”

Rx Price Watch Report Methodology
AARP’s Public Policy Institute, in collaboration with the PRIME Institute at the University of Minnesota, developed a market basket of 227 brand name prescription drug products widely used by older Americans. Using data from the Truven Health MarketScan® Research Databases, the report analyzed retail price changes between 2006 and 2013 for the drug products in the market basket. The medications include products used to treat common and often chronic health conditions, including high cholesterol, diabetes, and hypertension.
About AARP

AARP is a nonprofit, nonpartisan organization, with a membership of more than 37 million, that helps people turn their goals and dreams into real possibilities, strengthens communities and fights for the issues that matter most to families such as healthcare, employment and income security, retirement planning, affordable utilities and protection from financial abuse. We advocate for individuals in the marketplace by selecting products and services of high quality and value to carry the AARP name as well as help our members obtain discounts on a wide range of products, travel, and services. A trusted source for lifestyle tips, news and educational information, AARP produces AARP The Magazine, the world’s largest circulation magazine; AARP Bulletin; www.aarp.org; AARP TV & Radio; AARP Books; and AARP en Español, a bilingual news source. AARP does not endorse candidates for public office or make contributions to political campaigns or candidates. The AARP Foundation is an affiliated charity that provides security, protection, and empowerment to older persons in need with support from thousands of volunteers, donors, and sponsors. AARP has staffed offices in all 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. Learn more at www.aarp.org.

You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.

Recent Comments

Welcome to CopyLine Magazine! The first issue of CopyLine Magazine was published in November, 1990, by Editor & Publisher Juanita Bratcher. CopyLine’s main focus is on the political arena – to inform our readers and analyze many of the pressing issues of the day - controversial or otherwise. Our objectives are clear – to keep you abreast of political happenings and maneuvering in the political arena, by reporting and providing provocative commentaries on various issues. For more about CopyLine Magazine, CopyLine Blog, and CopyLine Television/Video, please visit juanitabratcher.com, copylinemagazine.com, and oneononetelevision.com. Bratcher has been a News/Reporter, Author, Publisher, and Journalist for 33 years. She is the author of six books, including “Harold: The Making of a Big City Mayor” (Harold Washington), Chicago’s first African-American mayor; and “Beyond the Boardroom: Empowering a New Generation of Leaders,” about John Herman Stroger, Jr., the first African-American elected President of the Cook County Board. Bratcher is also a Poet/Songwriter, with 17 records – produced by HillTop Records of Hollywood, California. Juanita Bratcher Publisher

Recent Posts